Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by KPOIndustrieson Nov 15, 2019 11:15am
107 Views
Post# 30356588

RE:RE:RE:RE:RE:RE:So according to Tripp

RE:RE:RE:RE:RE:RE:So according to Tripp
Liked2Think wrote: https://investorintel.com/sectors/biotech-healthcare/biotech-news/stagezero-life-sciences-announces-q3-2019-progress-update/

T
ests in Q3 approximately 1500?

so we always have approximately 1500 tests each quarter?  No increase ever?  No sign that they are doing anything to get more buisness?  How sure are we they were even close to 1500 tests?  How is it they have to "approximate" that?  If the current system they have in place cant tell the exact number of tests they have done how much confidence does that prove?

Ive had stocks go to zero before but never have I been so misslead by the ceo of of those companies.  The stuff James has said and none of it is even close to being a reality?  How is it possible in this day in age after the companies like Enron a ceo can say the stuff he has said and there is no accountability?

I couldn't agree more. There appeas to be no accountability. The company reiterates the same BS every quarter with no results, just excuses. Also, what kind of practice is this where they are running all of these tests without billing??? Nobody works for free. I feel like there are a lot of "donated tests" or offerings where they are not getting revenue. It is SHOCKING that the company is going further in debt after all of these "deals" they have signed and the advancement of "tele-health". Tele-health sounds like a scam/cop-out. Are you telling me people are going to sit and call from their house regarding a pre-screening product that they aren't even aware of???? That's obsurd. If StageZero doesn't begin to mass-market ColonSentry, we will continue to see 1500 tests.
Bullboard Posts